Last reviewed · How we verify
NCT03257293
A Trial of a Modified Cystoscopy Method to Reduce Pain Perception
NA trial testing Modified Cystoscopy in Hematuria in 93 participants. Completed in 1 August 2020.
1 August 2020
Quick facts
| Lead sponsor | Western University, Canada |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 93 |
| Start date | 1 April 2018 |
| Primary completion | 1 August 2020 |
| Estimated completion | 1 August 2020 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Modified Cystoscopy
- Routine Cystoscopy
Conditions studied
- Hematuria — all drugs for Hematuria →
- Bladder Cancer — all drugs for Bladder Cancer →
- Bladder Disease — all drugs for Bladder Disease →
Sponsor
Western University, Canada
Who can join
18 and older, any sex, with Hematuria or Bladder Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this project is to improve patient experience of cystoscopy using a non-pharmacologic modification of procedure. Cystoscopy is a common outpatient procedure for urology patients and is usually performed without sedation. However, there is limited research into reduction of patient discomfort throughout this procedure. The proposed modification technique was selected based on a well-documented psychological phenomenon in which only particular moments over the course of an aversive event determine the resultant perception of the experience. It is hypothesized that implementation of the technique will decrease the recalled pain intensity of the cystoscopy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03257293
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hematuria
Currently open trials in the same condition.
- NCT07037589 — Women With isoLated acUte cyStitis and Macroscopic Hematuria. Is Further Investigation Needed? · recruiting
- NCT07395037 — A Study of Ward Admissions for Haematuria · recruiting
- NCT06026189 — Safely Reduce Cystoscopic Evaluations for Hematuria Patients · NA · recruiting
- NCT05620784 — Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP · Phase 3 · recruiting
Other Western University, Canada trials
Trials by the same sponsor.
- NCT07485062 — Exercise and Diabetes Interventions to Improve Brain Health in Older Adults With Type 2 Diabetes · Phase 4 · not yet recruiting
- NCT07372755 — Feasibility and Usability of a Mobile App for Monitoring and Managing Functional Movement Disorders · not yet recruiting
- NCT07302308 — Action Outcome Latencies as a Measure of Sense of Agency in Functional Movement Disorders. · not yet recruiting
- NCT04323423 — The DURATION Study: reDUcing sedentaRy behAviour to Maintain cogniTIve functiON. · NA · withdrawn
- NCT07204301 — Enhancing Patient Comfort and Reducing Anxiety During Flexible Cystoscopy and Bladder Instillation in Bladder Cancer Pat · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03257293 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Western University, Canada
- Last refreshed: 27 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03257293.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing